Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

The Effects on Growth and Tolerance of a Routine Infant Formula Fed to Term Infants

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Mead Johnson Nutrition
ClinicalTrials.gov Identifier:
NCT02132663
First received: May 5, 2014
Last updated: April 30, 2015
Last verified: April 2015
  Purpose
This clinical trial will evaluate an investigational infant formula with an alternate source of DHA to determine if it provides normal growth and if it is well tolerated by term infants as compared to a marketed routine infant formula.

Condition Intervention
Growth of Term Infants
Other: Control: Marketed routine infant formula
Other: An investigational infant formula containing an alternate source of DHA

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double Blind (Participant, Care Provider, Investigator, Outcomes Assessor)
Official Title: The Effects on Growth and Tolerance of a Routine Infant Formula Fed to Term Infants

Resource links provided by NLM:


Further study details as provided by Mead Johnson Nutrition:

Primary Outcome Measures:
  • Body weight measured at each study visit [ Time Frame: 3.5 Months ]

Secondary Outcome Measures:
  • Recall of infant formula intake at each study visit [ Time Frame: 3.5 months ]
  • Body length measured at each study visit [ Time Frame: 3.5 months ]
  • Recall of stool consistency measured at each study visit [ Time Frame: 3.5 months ]
  • Medically-confirmed adverse events collected throughout the study period [ Time Frame: 3.5 months ]
  • Head circumference measured at each study visit [ Time Frame: 3.5 months ]
  • Recall of gastrointestinal tolerance measured at each study visit [ Time Frame: 3.5 months ]
  • Blood Collection [ Time Frame: Once at 120 days of age ]
    Blood Collection from a subset of participants to measure levels of fatty acids such as docosahexaenoic acid (DHA) and arachidonic acid (ARA).


Estimated Enrollment: 315
Study Start Date: May 2014
Study Completion Date: April 2015
Primary Completion Date: March 2015 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Infant formula containing an alternate source of DHA Other: An investigational infant formula containing an alternate source of DHA
Active Comparator: Marketed routine infant formula Other: Control: Marketed routine infant formula

  Eligibility

Ages Eligible for Study:   up to 14 Days   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Singleton, 10-14 days of age at randomization
  • Term infant with birth weight of a minimum of 2500 grams
  • Solely formula fed
  • Signed Informed Consent and Protected Health Information

Exclusion Criteria:

  • History of underlying metabolic or chronic disease or immunocompromised
  • Feeding difficulties or formula intolerance
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT02132663

Locations
United States, Alabama
Birmingham Pediatric Associates
Birmingham, Alabama, United States, 35205
Greenvale Pediatrics - Hoover
Birmingham, Alabama, United States, 35244
Southeastern Pediatric Association
Dothan, Alabama, United States, 36305
Pediatrics East - Alabama Clinical Therapeutics
Pinson, Alabama, United States, 35126
United States, Arkansas
Northwest Arkansas Pediatric Clinic
Fayetteville, Arkansas, United States, 72703
The Children's Clinic of Jonesboro, P.A.
Jonesboro, Arkansas, United States, 72401
United States, Connecticut
Norwich Pediatric Group, PC
Norwich, Connecticut, United States, 06360
United States, Florida
Children's Research, LLC
Altamonte Springs, Florida, United States, 32701
Physician Care Clinical Research
Sarasota, Florida, United States, 34239
United States, Indiana
Deaconess Clinical Research
Evansville, Indiana, United States, 47725
United States, Kentucky
Owensboro Pediatrics
Owensboro, Kentucky, United States, 42303
United States, Massachusetts
Woburn Pediatic Associates
Woburn, Massachusetts, United States, 01801
United States, North Carolina
Cary Pediatric Center
Cary, North Carolina, United States, 27511
Capital Pediatrics & Adolescent Center
Raleigh, North Carolina, United States, 27609
United States, Ohio
Pediatric Associates of Mt. Carmel, Inc
Cincinnati, Ohio, United States, 45245
Pediatric Associates of Fairfield, Inc.
Fairfield, Ohio, United States, 45014
UHMP Comprehensive Pediatrics
Westlake, Ohio, United States, 44145
United States, South Carolina
Coastal Pediatric Research
Charleston, South Carolina, United States, 29414
United States, Tennessee
The Jackson Clinic - North Jackson
Jackson, Tennessee, United States, 38305
Holston Medical Group
Kingsport, Tennessee, United States, 37660
United States, Texas
Austin Diagnostic Clinic
Austin, Texas, United States, 78745
DCOL Center for Clinical Research
Longview, Texas, United States, 75605
Sponsors and Collaborators
Mead Johnson Nutrition
Investigators
Study Director: Carol Lynn Berseth, M.D. Mead Johnson and Company
  More Information

Responsible Party: Mead Johnson Nutrition
ClinicalTrials.gov Identifier: NCT02132663     History of Changes
Other Study ID Numbers: 3386-1
Study First Received: May 5, 2014
Last Updated: April 30, 2015

ClinicalTrials.gov processed this record on May 24, 2017